Details for New Drug Application (NDA): 062617
✉ Email this page to a colleague
NDA 062617 describes NEOMYCIN SULFATE, POLYMYXIN B SULFATE & HYDROCORTISONE, which is a drug marketed by Pharmafair and is included in one NDA. Additional details are available on the NEOMYCIN SULFATE, POLYMYXIN B SULFATE & HYDROCORTISONE profile page.
The generic ingredient in NEOMYCIN SULFATE, POLYMYXIN B SULFATE & HYDROCORTISONE is hydrocortisone; neomycin sulfate; polymyxin b sulfate. There are sixty-seven drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the hydrocortisone; neomycin sulfate; polymyxin b sulfate profile page.
The generic ingredient in NEOMYCIN SULFATE, POLYMYXIN B SULFATE & HYDROCORTISONE is hydrocortisone; neomycin sulfate; polymyxin b sulfate. There are sixty-seven drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the hydrocortisone; neomycin sulfate; polymyxin b sulfate profile page.
Summary for 062617
| Tradename: | NEOMYCIN SULFATE, POLYMYXIN B SULFATE & HYDROCORTISONE |
| Applicant: | Pharmafair |
| Ingredient: | hydrocortisone; neomycin sulfate; polymyxin b sulfate |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | SUSPENSION/DROPS;OTIC | Strength | 1%;EQ 3.5MG BASE/ML;10,000 UNITS/ML | ||||
| Approval Date: | Sep 18, 1985 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
